Smith Group Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$647K Sell
2024
Q3
$770K Buy
2013
Q3
Sell
2013
Q2
$2.14M Buy